PK Study of Dapagliflozin in Pediatric Subjects With T2DM

NCT01525238 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Dapagliflozin
DRUG: Dapagliflozin
DRUG: Dapagliflozin

Sponsor

AstraZeneca

Collaborators

[object Object]